🇰🇷 South Korea Country × Condition
solid tumors Clinical Trials in South Korea
Active clinical trials for solid tumors with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05471856 Phase 1
Recruiting
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
Enrollment
66 pts
Country
🇰🇷 South Korea
Boehringer Ingelheim
View Trial → NCT06644755 Phase 1
Recruiting
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Enrollment
150 pts
Country
🇰🇷 South Korea
Daiichi Sankyo
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in South Korea?
There are currently 2 active clinical trials for solid tumors with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a solid tumors clinical trial in South Korea?
To join a solid tumors clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in South Korea?
Active solid tumors trials in South Korea span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology